Andere Sprachen Cipher Pharmaceuticals Inc.

Aktien

A0B85L

CA17253X1050

CPH

Markt geschlossen - Toronto S.E. Andere Börsenplätze 22:00:00 02.05.2024			% 5 Tage	% 1. Jan.
8.68 ^CAD	+1.17%		+2.12%	+56.68%

15.03.	Transcript : Cipher Pharmaceuticals Inc., Q4 2023 Earnings Call, Mar 15, 2024
14.03.	Cipher Pharmaceuticals Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference	03.04.
Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023.	14.03.
Cipher Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14.03.
Cipher Pharmaceuticals Q4 Profit Falls 61% on Charges	14.03.
Cipher Pharmaceuticals Brief: Q4 Net income and earnings per common share were US$7.7 million and $0.32, respectively	14.03.
Cipher Pharmaceuticals Brief: Q4 Total revenue was US$4.9 million, consistent with Q4 2022	14.03.
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results	14.03.
Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call	08.03.
Cipher Pharmaceuticals Brief: Announcing that its common shares are now trading on the OTCQX Best Market	29.01.
Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading	29.01.
Cipher Pharmaceuticals Announces Change of Auditor	27.11.
Cipher Pharmaceuticals Announces Change of Auditor	24.11.
Cipher Pharmaceuticals Announced Normal Course Issuer Bid	15.11.
Cipher Pharmaceuticals Announces Normal Course Issuer Bid	15.11.
Cipher Pharmaceuticals Brief: Announcing Normal Course Issuer Bid	15.11.
Cipher Pharmaceuticals Inc. announces an Equity Buyback for 1,337,195 shares, representing 5.57% of its issued share capital.	15.11.
Cipher Pharmaceuticals Inc. authorizes a Buyback Plan.	15.11.
Cipher Pharmaceuticals Seeks Acquisitions	10.11.
Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on September 19, 2022.	09.11.
Cipher Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Cipher Pharmaceuticals Inc.

Aktien

A0B85L

CA17253X1050

CPH

Andere Sprachen

Filter